JAK in the [Black] Box: A Dermatology Perspective on Systemic JAK Inhibitor Safety
Sarina B. Elmariah, Jeffrey S. Smith, Joseph F. Merola
Topics & Concepts
MedicineTofacitinibJanus kinasePsoriatic arthritisDermatologyAdverse effectSafety profileIntensive care medicinePsoriasisRheumatoid arthritisInternal medicineCytokineDermatology and Skin DiseasesPsoriasis: Treatment and PathogenesisAutoimmune Bullous Skin Diseases